FSD Pharma Inc Class B (HUGE)
Company Info
CA35954B2066
35954B206
Jun 8, 2018
Highlights
$66.67K
-$16.25
$3.50 - $31.98
$2.60
0.44%
0.11
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in FSD Pharma Inc Class B, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
HUGE
N/A
N/A
N/A
N/A
N/A
N/A
^GSPC (Benchmark)
-6.06%
-1.00%
-4.87%
8.34%
14.11%
10.27%
Monthly Returns
The table below presents the monthly returns of HUGE, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | -9.22% | 4.20% | -17.76% | -43.05% | -26.38% | -46.00% | -37.65% | -31.00% | -11.70% | 34.75% | -90.98% | ||
| 2023 | 35.72% | 64.49% | -11.93% | -3.87% | -28.19% | 7.48% | 1.74% | 10.26% | -6.16% | -14.09% | 0.96% | -12.40% | 16.67% |
| 2022 | -13.73% | 19.32% | -17.53% | 16.64% | -2.99% | -19.37% | 13.92% | 1.01% | -9.25% | 3.01% | -0.21% | -7.03% | -22.71% |
| 2021 | 28.85% | 2.49% | -7.28% | -5.76% | -1.67% | -1.69% | 0.57% | 4.57% | -13.66% | -12.03% | -13.67% | -15.00% | -34.62% |
| 2020 | 15.87% | -34.34% | -8.23% | -14.02% | -8.86% | 28.96% | -5.22% | -12.40% | -19.81% | -44.31% | 50.70% | -27.10% | -71.26% |
| 2019 | 24.59% | -21.16% | -15.28% | 5.62% | -18.62% | -18.30% | -28.39% | -13.64% | -10.74% | -55.59% | -21.92% | 12.86% | -87.37% |
| 2018 | 50.12% | -4.87% | 58.48% | 184.48% | -33.33% | -18.92% | -28.70% | 148.14% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
The current rank of HUGE is 5, meaning it’s performing worse than 95% of other stocks on our website when it comes to balancing risk and reward. Below is a breakdown of how it compares using common performance measures.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for FSD Pharma Inc Class B (HUGE) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Worst Drawdowns
The table below displays the maximum drawdowns of the FSD Pharma Inc Class B. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the FSD Pharma Inc Class B was 99.96%, occurring on Sep 3, 2024. The portfolio has not yet recovered.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -99.96% | Sep 24, 2018 | 1495 | Sep 3, 2024 | — | — | — |
| -33.33% | Jul 3, 2018 | 33 | Aug 17, 2018 | 8 | Aug 29, 2018 | 41 |
| -24.14% | Sep 11, 2018 | 3 | Sep 13, 2018 | 4 | Sep 19, 2018 | 7 |
| -16.22% | Jun 26, 2018 | 2 | Jun 27, 2018 | 3 | Jul 2, 2018 | 5 |
| -14.27% | Jun 11, 2018 | 4 | Jun 14, 2018 | 3 | Jun 19, 2018 | 7 |
Volatility
Volatility Chart
The current FSD Pharma Inc Class B volatility is 25.71%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.
Financials
Financial Performance
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |